Westside Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.9K | Hold |
991
| – | – | 0.01% | 578 |
|
|
2026
Q1 | $56.2K | Hold |
991
| – | – | 0.01% | 533 |
|
|
2025
Q4 | $49.2K | Hold |
991
| – | – | 0.01% | 547 |
|
|
2025
Q3 | $45.1K | Buy |
991
+492
| +99% | +$19.2K | 0.01% | 572 |
|
|
2025
Q2 | $19.4K | Buy |
+499
| New | +$19.1K | ﹤0.01% | 691 |
|
|
2025
Q1 | – | Sell |
-28
| Closed | -$947 | – | 993 |
|
|
2024
Q4 | $947 | Hold |
28
| – | – | ﹤0.01% | 945 |
|
|
2024
Q3 | $1.15K | Hold |
28
| – | – | ﹤0.01% | 943 |
|
|
2024
Q2 | $1.08K | Hold |
28
| – | – | ﹤0.01% | 944 |
|
|
2024
Q1 | $1.2K | Hold |
28
| – | – | ﹤0.01% | 851 |
|
|
2023
Q4 | $1.04K | Hold |
28
| – | – | ﹤0.01% | 826 |
|
|
2023
Q3 | $1.01K | Hold |
28
| – | – | ﹤0.01% | 799 |
|
|
2023
Q2 | $998 | Hold |
28
| – | – | ﹤0.01% | 801 |
|
|
2023
Q1 | $996 | Hold |
28
| – | – | ﹤0.01% | 793 |
|
|
2022
Q4 | $0 | Hold |
28
| – | – | ﹤0.01% | 816 |
|
|
2022
Q3 | $0 | Hold |
28
| – | – | ﹤0.01% | 818 |
|
|
2022
Q2 | $1 | Hold |
28
| – | – | ﹤0.01% | 778 |
|
|
2022
Q1 | $1 | Hold |
28
| – | – | ﹤0.01% | 758 |
|
|
2021
Q4 | $1 | Hold |
28
| – | – | ﹤0.01% | 752 |
|
|
2021
Q3 | $1 | Hold |
28
| – | – | ﹤0.01% | 731 |
|
|
2021
Q2 | $1 | Hold |
28
| – | – | ﹤0.01% | 719 |
|
|
2021
Q1 | $1 | Hold |
28
| – | – | ﹤0.01% | 702 |
|
|
2020
Q4 | $1 | Hold |
28
| – | – | ﹤0.01% | 625 |
|
|
2020
Q3 | $1 | Sell |
28
-180
| -87% | -$9.02K | ﹤0.01% | 634 |
|
|
2020
Q2 | $10 | Hold |
208
| – | – | ﹤0.01% | 481 |
|
|
2020
Q1 | $9 | Buy |
+208
| New | +$11.1K | ﹤0.01% | 479 |
|
|
2019
Q2 | $50 | Buy |
+1,008
| New | +$50.6K | ﹤0.01% | 310 |
|
|
2018
Q4 | $48.1K | Hold |
1,008
| – | – | 0.02% | 296 |
|
|
2018
Q3 | $50.5K | Hold |
1,008
| – | – | 0.02% | 261 |
|
|
2018
Q2 | $50.6K | Hold |
1,008
| – | – | 0.02% | 296 |
|
|
2018
Q1 | $49K | Sell |
1,008
-31
| -3% | -$1.44K | 0.03% | 288 |
|
|
2017
Q4 | $48.6K | Buy |
1,039
+31
| +3% | +$1.43K | 0.03% | 290 |
|
|
2017
Q3 | $51.2K | Hold |
1,008
| – | – | 0.03% | 267 |
|
|
2017
Q2 | $53.2K | Hold |
1,008
| – | – | 0.03% | 257 |
|
|
2017
Q1 | $52.8K | Sell |
1,008
-146
| -13% | -$7.41K | 0.03% | 253 |
|
|
2016
Q4 | $56.3K | Buy |
+1,154
| New | +$57K | 0.04% | 180 |
|
Other funds holding GSK
JEST
Westside Investment Management's GSK Position: Q2 2026 in Review
Westside Investment Management held its GSK (GSK) position steady in Q2 2026 at 991 shares worth $51.9K. The position accounts for 0.01% of the portfolio, ranked #578.
Westside Investment Management first reported a position in GSK in Q4 2016 and has held it in 35 quarters since. The position peaked at $56.3K in Q4 2016. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Westside Investment Management held 991 shares of GSK worth $51.9K as of Q2 2026.
- Westside Investment Management left its GSK share count unchanged in Q2 2026.
- GSK made up 0.01% of Westside Investment Management's portfolio in Q2 2026, its #578 holding.
- Westside Investment Management first reported a position in GSK in Q4 2016 and has held it in 35 quarters since.
- Westside Investment Management's GSK position peaked at $56.3K in Q4 2016.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.